Jinli USA Inc. located in Tustin, CA, is the subsidiary company of Shanghai Jinli Pharmaceutical Co., Ltd. responsible for sales and marketing to the North American Market.

Shanghai Jinli Pharmaceutical Co., Ltd. ("JINLI") was founded in 2008, is a high-tech manufacturer in nutraceuticals and pharmaceutical ingredients. JINLI covers an area of 50,000 square meters and now has 200 employees, more than 30% of them are senior and middle-level professionals and technicians.

JINLI strives to be a market leader in both quality and volume for the ingredients. JINLI currently provides Pyridoxal-5-Phosphate Monohydrate(P5P), L-5-Methyltetrahydrofolate Calcium( L-5-MTHF-Ca), Creatine Pyruvate with many more products in a well-established research and development process.

Based on risk and science, JINLI has established cGMP quality management system. In 2009, JINLI acquired the ISO certifications of quality system and environmental safety system. In 2023 JINLI obtained the Drug Manufacturing License and in 2024 obtained the Food Manufacturing License. With excellent technics, QEHS management system and good service, JINLI enjoys a good reputation and has established good business relationships with several Fortune 500 companies.